Cargando…

P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE

Detalles Bibliográficos
Autores principales: Liu, Weiyang, Liu, Yuanfang, Zhu, Yongmei, Weng, Xiangqin, Wang, Cheng, Ouyang, Wanyan, Xu, Jie, Wang, Jin, MI, Jian‑qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429187/
http://dx.doi.org/10.1097/01.HS9.0000968392.21249.a8
_version_ 1785090647965827072
author Liu, Weiyang
Liu, Yuanfang
Zhu, Yongmei
Weng, Xiangqin
Wang, Cheng
Ouyang, Wanyan
Xu, Jie
Wang, Jin
MI, Jian‑qing
author_facet Liu, Weiyang
Liu, Yuanfang
Zhu, Yongmei
Weng, Xiangqin
Wang, Cheng
Ouyang, Wanyan
Xu, Jie
Wang, Jin
MI, Jian‑qing
author_sort Liu, Weiyang
collection PubMed
description
format Online
Article
Text
id pubmed-10429187
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104291872023-08-17 P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE Liu, Weiyang Liu, Yuanfang Zhu, Yongmei Weng, Xiangqin Wang, Cheng Ouyang, Wanyan Xu, Jie Wang, Jin MI, Jian‑qing Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429187/ http://dx.doi.org/10.1097/01.HS9.0000968392.21249.a8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Liu, Weiyang
Liu, Yuanfang
Zhu, Yongmei
Weng, Xiangqin
Wang, Cheng
Ouyang, Wanyan
Xu, Jie
Wang, Jin
MI, Jian‑qing
P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE
title P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE
title_full P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE
title_fullStr P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE
title_full_unstemmed P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE
title_short P370: EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN ADULTS PH/BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA WITH T315I MUTATION AND RELAPSED/REFRACTORY DISEASE
title_sort p370: efficacy and safety of the third-generation tki olverembatinib in adults ph/bcr-abl1-positive acute lymphoblastic leukemia with t315i mutation and relapsed/refractory disease
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429187/
http://dx.doi.org/10.1097/01.HS9.0000968392.21249.a8
work_keys_str_mv AT liuweiyang p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease
AT liuyuanfang p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease
AT zhuyongmei p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease
AT wengxiangqin p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease
AT wangcheng p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease
AT ouyangwanyan p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease
AT xujie p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease
AT wangjin p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease
AT mijianqing p370efficacyandsafetyofthethirdgenerationtkiolverembatinibinadultsphbcrabl1positiveacutelymphoblasticleukemiawitht315imutationandrelapsedrefractorydisease